News & Press Releases

Podcaster Richard Hsu interviewed San Francisco Managing Member Steve Osborn on his podcast Hsu Untied. In the episode, Steve reflects on his career journey, including his start in law school to becoming an attorney advising on international work in London and Hong Kong, and his rise from launching a boutique firm to his current role as a tech and life sciences-focused Managing Member. Steve also highlights the importance of calculated risks for professional growth.

The Cigna Health Group signed a deal selling its Medicare businesses to Health Care Service Corporation (HCSC) for $3.7 billion. A Mintz team led by Tara Dwyer and Lauren Moldawer acted as regulatory counsel to The Cigna Group on the sale. In the deal, which is expected to close in the first quarter of 2025, HCSC will acquire Cigna’s Medicare lines including Medicare Advantage, Medicare supplement, and Medicare drug plans, as well as CareAllies, a unit that works with physician groups and other healthcare providers.

Fiduciary News spoke to Of Counsel Michelle Capezza on the impact of the SEC’s approval of the creation of Bitcoin ETFs on 401k plan sponsors.

Antitrust Co-Chair Bruce Sokler shared his insights with the National Law Journal on Andrew Ferguson and Melissa Holyoak’s nominations to the Federal Trade Comission. Bruce acknowledged that both Ferguson and Holyoak have state-level experience, which could be a “useful perspective” on the commission.

MDDI interviewed Of Counsel Benjamin Zegarelli on the controversy surrounding the FDA’s proposed regulation to oversee laboratory-developed tests (LDT) and his thoughts on the future of LDTs.

The US International Trade Commission has ruled in favor of Advanced Micro Devices Inc. (AMD), represented by IP Chair Michael Renaud in a high-profile patent infringement case. The ITC’s final determination found that several companies, including major Chinese manufacturer TCL Industries Holding, violated federal law by importing digital televisions and other products infringing on an AMD US patent. This decision resulting in a limited exclusion order and cease-and-desist against the infringing companies underscores the strength of AMD’s patented semiconductor processor technology.